VIVE
(NASDAQ)
0.7300
-0.0134  (-1.84%)
Volume (24h): 168.18K Day Range: 0.7051 - 0.7833
Market Cap: 6.24M 52W Range: 0.0750 - 9.90
Mar-27-20 01:38AM Edited Transcript of VIVE earnings conference call or presentation 19-Mar-20 9:00pm GMTThomson Reuters StreetEvents
Mar-26-20 08:48PM Edited Transcript of VIVE earnings conference call or presentation 19-Mar-20 9:00pm GMTThomson Reuters StreetEvents
12:28PM Viveve Announces Clearance of Next Generation 2.0 System in TaiwanACCESSWIRE
Mar-19-20 08:01PM Viveve Reports Full Year 2019 Financial ResultsACCESSWIRE
07:00PM Viveve Medical, Inc. to Host Earnings CallACCESSWIRE
Mar-12-20 12:28PM Viveve Announces Completion of VIVEVE II Pivotal FDA Clinical Trial for Improvement of Sexual FunctionACCESSWIRE
Mar-06-20 01:28PM Viveve to Host Conference Call to Provide Corporate Update and Year-End 2019 Financial Results on March 19, 2020ACCESSWIRE
Mar-04-20 01:28PM Viveve Completes Enrollment in Short-Term Feasibility Study for Stress Urinary IncontinenceACCESSWIRE
Feb-19-20 01:05PM Benzinga Pro's Top 5 Stocks To Watch For Wed., Feb. 19, 2020: BLPH, GRPN, VIVE, CODX, GNPXBenzinga
Jan-14-20 01:28PM Viveve Initiates Enrollment of its Short-Term Feasibility Study in Stress Urinary IncontinenceACCESSWIRE
Jan-02-20 03:19PM Company News For Jan 2, 2020Zacks
Dec-31-19 01:28PM Viveve Announces Compliance with Nasdaq Listing RulesACCESSWIRE
Dec-18-19 01:28PM Viveve Announces Authorization to Initiate Short-Term Feasibility Study in Stress Urinary Incontinence from Canadian Ministry of HealthACCESSWIRE
Dec-10-19 01:28PM Viveve Announces Clearance of Next Generation 2.0 System in South KoreaACCESSWIRE
Dec-03-19 01:28PM Viveve Announces Launch of Viveve 2.0 System in ChinaACCESSWIRE
Nov-26-19 09:02PM Viveve Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment OptionACCESSWIRE
08:33AM Edited Transcript of VIVE earnings conference call or presentation 7-Nov-19 10:00pm GMTThomson Reuters StreetEvents
Nov-26-19 05:13AM Edited Transcript of VIVE earnings conference call or presentation 7-Nov-19 10:00pm GMTThomson Reuters StreetEvents
Nov-22-19 06:50PM Viveve Announces Pricing of $10 Million Underwritten Public OfferingACCESSWIRE
Nov-09-19 12:11AM Edited Transcript of VIVE earnings conference call or presentation 7-Nov-19 10:00pm GMTThomson Reuters StreetEvents
Nov-08-19 08:58AM Edited Transcript of VIVE earnings conference call or presentation 7-Nov-19 10:00pm GMTThomson Reuters StreetEvents
Nov-07-19 09:02PM Viveve Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateACCESSWIRE
12:18PM The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOsBenzinga
Oct-24-19 12:02PM Viveve to Host Conference Call to Provide Corporate Update and Third Quarter 2019 Results on November 7, 2019ACCESSWIRE
Oct-11-19 12:49PM Viveve Medical stock plunges toward record low after filing to sell more sharesMarketWatch
Oct-04-19 05:48PM Waiting For OctoberBenzinga
Oct-01-19 04:58PM A Look At Benzinga Pro's Most-Searched Tickers For October 1, 2019Benzinga
12:02PM Viveve Raises $6.76 million Through Completion of At-The-Market Equity FinancingACCESSWIRE
Sep-19-19 12:28PM Viveve Submits Investigational Testing Application to Conduct Short-Term Feasibility Study in Stress Urinary IncontinenceACCESSWIRE
Sep-18-19 02:00PM Viveve and its New CEO are Pioneering Women's Intimate HealthACCESSWIRE
12:28PM Viveve Announces Reverse Stock Split to Regain NASDAQ ComplianceACCESSWIRE
Sep-17-19 12:28PM Viveve to Present at the Ladenburg Thalmann 2019 Healthcare ConferenceACCESSWIRE
Sep-06-19 03:00AM Edited Transcript of VIVE earnings conference call or presentation 8-Aug-19 8:30pm GMTThomson Reuters StreetEvents
Sep-03-19 08:02PM Viveve to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceACCESSWIRE
12:28PM Viveve Signs Exclusive Distribution Partnership with Paragon Meditech in Hong Kong, China and MacauACCESSWIRE
Aug-22-19 12:28PM Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical SolutionsACCESSWIRE
Aug-08-19 08:02PM Viveve Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateACCESSWIRE
Aug-07-19 08:02PM Viveve Reports Additional Clinical Results of LIBERATE-International Trial for Stress Urinary IncontinenceACCESSWIRE
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)